Spots Global Cancer Trial Database for psoriasis
Every month we try and update this database with for psoriasis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet | NCT00585650 | Psoriasis | Etanercept Placebo injecti... | 18 Years - 70 Years | University of California, Irvine | |
| Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer | NCT03816345 | Autoimmune Dise... Crohn Disease Dermatomyositis Hematopoietic a... Inflammatory Bo... Malignant Solid... Multiple Sclero... Psoriasis Psoriatic Arthr... Rheumatoid Arth... Sjogren Syndrom... Systemic Lupus ... Systemic Sclero... Ulcerative Coli... | Biospecimen Col... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| PatientSpot Formerly Known as ArthritisPower | NCT03840928 | Rheumatoid Arth... Ankylosing Spon... Fibromyalgia Gout Crohn Disease Juvenile Idiopa... Lupus Erythemat... Myositis Osteoarthritis Osteoporosis Psoriasis Psoriatic Arthr... Scleroderma Dermatomyositis Inflammatory Bo... Polymyositis Axial Spondyloa... Diffuse Idiopat... Polymyalgia Rhe... Giant Cell Arte... Temporal Arteri... Wegener Relapsing Polyc... Undifferentiate... Spinal Cord Inj... Alzheimer Disea... Amyotrophic Lat... Ataxia Bell Palsy Brain Tumor Cerebral Aneury... Epilepsy Guillain-Barre ... Headache Head Injury Hydrocephalus Lumbar Disc Dis... Meningitis Multiple Sclero... Muscular Dystro... Neurocutaneous ... Parkinson Disea... Stroke Cluster Headach... Tension-Type He... Chronic Obstruc... Asthma Lung Cancer Cystic Fibrosis Sleep Apnea Eczema Alopecia Chronic Inflamm... Unstable Angina Heart Attack Heart Failure Arrythmia Valve Heart Dis... High Blood Pres... Congenital Hear... Peripheral Arte... Diabetes Chronic Liver D... Obesity | 19 Years - | Global Healthy Living Foundation | ||
| The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists | NCT00224562 | Rheumatoid Arth... Crohn's Disease Ankylosing Spon... Psoriasis | TNF-alpha antag... | 0 Years - | Assistance Publique - Hôpitaux de Paris | |
| Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain | NCT01351805 | Autoimmune Dise... Systemic Inflam... Knee Pain Chron... Osteoarthritis Rheumatoid Arth... | Fish Oil Vitamin D placebo pill | 50 Years - | Brigham and Women's Hospital | |
| Post-Marketing Surveillance Study of OTEZLA | NCT03284879 | Psoriasis | - | Amgen | ||
| Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study | NCT02196701 | Psoriasis | Adalimumab Methotrexate | 18 Years - 99 Years | AbbVie | |
| TYK2 Inhibition in Paradoxical Psoriasis | NCT06281106 | Psoriasis | Deucravacitinib | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | NCT03941184 | SCAD Addison Disease Ankylosing Spon... Antiphospholipi... Celiac Disease Crohn Disease Dermatomyositis Polymyositis Guillain-Barre ... Hepatitis, Auto... Graves Disease Hashimoto Thyro... Multiple Sclero... Myasthenia Grav... Pernicious Anem... Polymyalgia Rhe... Primary Biliary... Psoriasis Rheumatoid Arth... Systemic Sclero... Sjögren Syndrom... Systemic Lupus ... Takayasu Arteri... Type 1 Diabetes... Ulcerative Coli... Uveitis Vasculitis Vitiligo Raynaud | 18 Years - 110 Years | Mayo Clinic | ||
| Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | NCT05635266 | Age-Related Mac... Allergies Alpha-Gal Syndr... Alzheimer Disea... Amyloidosis Ankylosing Spon... Arthritis Alopecia Areata Asthma Atopic Dermatit... Autism Autoimmune Hepa... Behcet's Diseas... Beta-Thalassemi... Cancer Celiac Disease Kidney Diseases COPD Crohn Disease Cystic Fibrosis Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Disease... Hepatitis Hidradenitis Su... ITP Leukemia ALS Lupus or SLE Lymphoma Multiple Sclero... Myasthenia Grav... Heart Diseases Parkinson Disea... Pemphigus Vulga... Cirrhosis Psoriasis Schizophrenia Scleroderma Sickle Cell Dis... Stroke Ulcerative Coli... Vasculitis Vitiligo | Specimen sample | 18 Years - 85 Years | Sanguine Biosciences | |
| Mechanism of Action Study for Psoriasis | NCT00932113 | Psoriasis | Methotrexate Adalimumab (Hum... | 18 Years - 85 Years | Tufts Medical Center | |
| The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases | NCT00005660 | Basal Cell Carc... Keratosis Palma... Psoriasis | - | National Institutes of Health Clinical Center (CC) | ||
| Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study | NCT02196701 | Psoriasis | Adalimumab Methotrexate | 18 Years - 99 Years | AbbVie | |
| The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis | NCT01504113 | Psoriasis | 20 Years - 90 Years | National Taiwan University Hospital | ||
| Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions | NCT00129415 | Atopic Dermatit... Psoriasis Alopecia Mycosis Fungoid... Urticaria Dermatoses Stretch Marks | UVA1 Irradiatio... UVB Irradiation | 10 Years - 80 Years | University of Michigan | |
| HIV Indicator Diseases in Hospital and Primary Care | NCT05225493 | HIV Infections Primary Health ... Acquired Immuno... Sexually Transm... Herpes Zoster Dermatitis, Seb... Pneumonia Infectious Mono... Psoriasis Candida Infecti... Lymphadenopathy Uterine Cervica... Weight Loss Diarrhea Chroni... Leukopenia Thrombocytopeni... AIDS Defining I... HIV Indicator C... | Peer to peer fe... HIV rapid test | 18 Years - | Erasmus Medical Center | |
| Potential Research Study Participant Registry | NCT00710489 | Acne Actinic Keratos... Dysplastic Nevi Eczema Psoriasis Skin Cancer Rosacea Leg Ulcers Foot Ulcers Atopic Dermatit... | 18 Years - | University of California, Davis | ||
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease | NCT03656627 | Autoimmune Dise... Non-small Cell ... Rheumatoid Arth... Psoriasis Giant Cell Arte... Polymyalgia Rhe... Systemic Lupus ... Crohn Disease Multiple Sclero... Ulcerative Coli... | Nivolumab | 18 Years - | Alliance Foundation Trials, LLC. | |
| Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants. | NCT01961609 | Psoriasis | Secukinumab (AI... | 18 Years - | Novartis | |
| Can We Miss Pigmented Lesions in Psoriasis Patients? | NCT01053819 | Psoriasis Melanoma Non-melanoma Sk... | etanercept | 19 Years - | University of Alabama at Birmingham | |
| Post-Marketing Surveillance Study of OTEZLA | NCT03284879 | Psoriasis | - | Amgen | ||
| Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study | NCT02196701 | Psoriasis | Adalimumab Methotrexate | 18 Years - 99 Years | AbbVie | |
| Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis | NCT02762955 | Psoriasis | BCD-057 Humira® | 18 Years - 75 Years | Biocad | |
| A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis | NCT05796245 | Arthritis, Rheu... Colitis, Ulcera... Crohn Disease Psoriasis | 15 Years - | Pfizer | ||
| Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis | NCT02762955 | Psoriasis | BCD-057 Humira® | 18 Years - 75 Years | Biocad | |
| Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) | NCT03253666 | Skin Cancer Melanoma Non-melanoma Sk... Psoriasis Rosacea Lupus Erythemat... Atopic Dermatit... | Nutrient Intake | - | Harvard School of Public Health (HSPH) | |
| Apremilast Pregnancy Exposure Registry | NCT02775500 | Psoriatic Arthr... Psoriasis | apremilast | - | University of California, San Diego | |
| Potential Research Study Participant Registry | NCT00710489 | Acne Actinic Keratos... Dysplastic Nevi Eczema Psoriasis Skin Cancer Rosacea Leg Ulcers Foot Ulcers Atopic Dermatit... | 18 Years - | University of California, Davis | ||
| TYK2 Inhibition in Paradoxical Psoriasis | NCT06281106 | Psoriasis | Deucravacitinib | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet | NCT00585650 | Psoriasis | Etanercept Placebo injecti... | 18 Years - 70 Years | University of California, Irvine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
